Envision Healthcare. KKR''s 2018 take-private and the bankruptcy that followed
A $9.9B deal that became the largest healthcare-services bankruptcy in PE history
The deal. In June 2018, KKR took Envision Healthcare private for $9.9 billion ($46/share). At the time the largest healthcare-services LBO. Envision provided emergency medicine staffing (under the EmCare brand) and ambulatory surgery centers. The capital structure was approximately 80% debt. Over $7 billion in obligations including notably aggressive incurrence covenants.
The thesis. Envision had market-leading positions in two healthcare-services segments (emergency medicine staffing and ambulatory surgery), favorable industry structure (hospitals continuing to outsource physician staffing), and a path to operational improvement through scale economics. KKR believed the deal could generate strong returns through margin expansion, M&A, and eventual re-IPO.
What they did. KKR pursued operational improvements and continued M&A activity in the first two years. However, two events disrupted the thesis: First, the 2020 No Surprises Act fundamentally restricted Envision's ability to balance-bill out-of-network patients. A major historical revenue source. Second, COVID-19 dramatically reduced elective surgical procedures (Envision's ambulatory surgery business) and reshaped emergency-room volumes. Debt service became unsustainable.
The outcome. Envision filed Chapter 11 bankruptcy in May 2023 with $7.7 billion in debt against deteriorated cash flow. KKR's equity was almost completely wiped out. Among the largest single-deal equity losses in healthcare-services PE history. The bankruptcy reorganization transferred ownership to debt-holders. The deal became a case study in the dangers of high-leverage healthcare PE in a shifting regulatory environment.
Best practices for VantageOS users. First, healthcare regulatory risk now requires explicit scenario modeling. Not just sensitivity analysis but binary "what if surprise billing is eliminated" stress tests. The asymmetry (upside bounded, downside catastrophic) demands conservative leverage. Second, COVID-19 demonstrated that even "stable" healthcare services have catastrophic-event exposure that traditional underwriting doesn't capture. Build in much greater downside reserves. Third, the healthcare-services LBO model that worked from 2010-2018 (high leverage on stable cash flow with billing-arbitrage upside) is structurally broken in the current environment. New healthcare PE strategies need clinical-quality and patient-experience moats, not financial engineering on regulated revenue streams.